AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar line70day (24.50) Submitted: 1/21/2013 11:34:01 AM : Outperform Start Price: $0.00 ACRX Score: 0

up 30% after excellent results with drug sufentanil nonotab pca1yr change 81.31%

Report this Post Reply

Featured Broker Partners


Advertisement